Hepatocellular redistribution of multidrug resistant protein (MRP2): A compensatory mechanism in antidepressant induced cholestasis

被引：0
|
作者：
Milkiewicz, P
Chilton, A
Hubscher, SG
Elias, E
机构：
[1] Univ Birmingham, Dept Pathol, Birmingham, W Midlands, England
[2] Pomeranian Med Sch, Dept Gastroenterol, Szczecin, Poland
[3] Queen Elizabeth Hosp, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England
来源：
GUT | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
388
引用
收藏
页码：A105 / A105
页数：1
相关论文
共 50 条
  • [41] Alterations in nuclear hormone receptors (NHR) are associated with changes in the expression of multidrug resistance proteins Mrp2 and Mrp3 in liver and kidney in cholestasis.
    Denson, LA
    Bohan, A
    Bajwa, HJ
    Held, MA
    Boyer, JL
    HEPATOLOGY, 2001, 34 (04) : 264A - 264A
  • [42] Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human
    Li, Na
    Zhang, Yiqun
    Hua, Fengmei
    Lai, Yurong
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (01) : 66 - 73
  • [43] Activity and expression of the multidrug resistance protein MRP1 and MRP2 in acute myeloid leukemia (AML) cells.
    VanderKolk, DM
    deVries, EGE
    Koning, JA
    VandenBerg, E
    Muller, M
    Vellenga, E
    BLOOD, 1997, 90 (10) : 801 - 801
  • [44] Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein 2 (MRP2) inhibitors
    Mosaffa, Fatemeh
    Hadizadeh, Farzin
    Fathi, Faezeh
    Nasab, Zahra Eslami
    Pourzahed, Tahereh
    Aboutorabzade, Sayyed Mohammad
    Ghodsi, Razieh
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 24 (06) : 815 - 824
  • [45] Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
    M Yamasaki
    T Makino
    T Masuzawa
    Y Kurokawa
    H Miyata
    S Takiguchi
    K Nakajima
    Y Fujiwara
    N Matsuura
    M Mori
    Y Doki
    British Journal of Cancer, 2011, 104 : 707 - 713
  • [46] Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene
    Stöckel, B
    König, J
    Nies, AT
    Cui, Y
    Brom, M
    Keppler, D
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (05): : 1347 - 1358
  • [47] Multidrug resistance-related protein 2 (Mrp2) deficiency does not enhance acute cyclosporine A nephrotoxicity
    Grisk, Olaf
    Maehler, Nicole
    Freyer, Martin
    Kauschke, Rene
    Schlueter, Torsten
    Steinbach, Antje
    Rettig, Rainer
    FASEB JOURNAL, 2011, 25
  • [48] Expression of the hepatocyte canalicular multidrug resistance associated protein 2 (MRP2) in primary biliary cirrhosis.
    Oswald, M
    Kullak-Ublick, GA
    Beuers, U
    Paumgartner, G
    HEPATOLOGY, 1998, 28 (04) : 544A - 544A
  • [49] Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
    Yamasaki, M.
    Makino, T.
    Masuzawa, T.
    Kurokawa, Y.
    Miyata, H.
    Takiguchi, S.
    Nakajima, K.
    Fujiwara, Y.
    Matsuura, N.
    Mori, M.
    Doki, Y.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 707 - 713
  • [50] Rapid, Nongenomic Stimulation of Multidrug Resistance Protein 2 (Mrp2) Activity by Glucocorticoids in Renal Proximal Tubule
    Prevoo, Brigitte
    Miller, David S.
    van de Water, Femke M.
    Wever, Kimberley E.
    Russel, Frans G. M.
    Flik, Gert
    Masereeuw, Rosalinde
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01): : 362 - 371
12345